Am J Transplant, Volume 18, Suppl 3 Archives - Page 117 of 211 - ATC Abstracts

2018 American Transplant Congress
A Protocol for the Management of Alemtuzumab Induced Leukopenia in Kidney Transplant Recipients
S. Hammad, B. Ravichandran, M. Crist, B. Masters.
University of Maryland Medical Center, Baltimore.
Purpose: Leukopenia is a common complication following alemtuzumab induction in kidney transplant recipients (KTR), often limiting its use. Our institution developed a protocol to manage…
2018 American Transplant Congress
Burden of Infectious Complications after Upper Extremity Allotransplantation: A Matched Cohort Study
A. Conrad,^1,2,3 P. Petruzzo,^4,5 J. Kanitakis,⁶ A. Gazarian,⁷ L. Badet,^3,8 P. Vanhems,^3,9 O. Thaunat,^1,3,10 E. Morelon,^1,3,10 A. Sicard.^1,3
¹Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon (HCL), Lyon, France; ²Department of Infectious Diseases and Tropical Medicine, HCL, Lyon, France; ³Claude Bernard Lyon 1 University, Lyon, France; ⁴Department of Transplantation, HCL, Lyon, France; ⁵Department of Surgery, University of Cagliari, Cagliari, Italy; ⁶Department of Dermatology, HCL, Lyon, France; ⁷Clinique du Parc, Lyon, France; ⁸Department of Urology and Transplantation, HCL, Lyon, France; ⁹Infection Control and Epidemiology Unit, HCL, Lyon, France; ¹⁰INSERM U1111, International Center for Infectiology Research, Lyon, France.
This study aimed to assess the infectious risk after upper extremity allotransplantation (UEA), a non-vital transplantation procedure requiring lifelong immunosuppression. A matched cohort study was…
2018 American Transplant Congress
Solid Organ Transplantation and Data Mining: Risk Factors for Invasive Fungal Disease in Heart Transplant Recipients
N. Barros, D. Xie, C. Yek, T. Liu, X. Li, B. Adams-Huet, J. Martinez, S. Garg, J. Grodin, R. Morelend, A. Amin, F. Aras, J. Thibodeau, P. Mammen, M. Peltz, M. Drazner, W. Ring, R. Haley, R. La Hoz.
UT Southwestern, Dallas, TX.
We created a database of solid organ transplant (SOT) recipients using innovative data mining tools. This study describing the epidemiology of invasive fungal disease (IFD)…
2018 American Transplant Congress
Detection of Different Gene Expression Profiles in CD8⁺ T Cells from Chronic High EBV Load Carriers after Pediatric Heart and Liver Transplantation
M. Yamada,^1,2 C. Macedo,² X. Gu,² M. Michaels,^1,2 M. Green,^1,2 C. Nguyen,^1,2 U. Chandran,³ B. Feingold,^1,2 G. Mazariegos,^1,2 D. Metes.^1,2
¹Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA; ²Thomas E. Starzl Transplantation Institute, Pittsburgh, PA; ³Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA.
Background: EBV infection and post-transplant lymphoproliferative disorders (PTLD) are life-threatening complications of pediatric solid organ transplantation (Tx). The risk for PTLD varies by transplanted organ,…
2018 American Transplant Congress
Containment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections at a Solid Organ Transplant Centre
A. Mularoni,¹ G. Martucci,¹ S. Gruttadauria,¹ M. Campanella,¹ F. Tuzzolino,¹ G. Arena,¹ A. Arcadipane,¹ U. Palazzo,¹ A. Luca,¹ B. Gridelli,¹ P. Grossi.²
¹ISMETT-IRCCS, Palermo, Italy; ²University of Insubria, Varese, Italy.
Objectives The aim is to describe epidemiology and analyze the effectiveness of the intervention in CRE containment in SOT patients (pts).Methods In 2012 a taskforce…
2018 American Transplant Congress
Linking Donor Ischemia Reperfusion Injury (IRI) to Costimulatory Blockade Resistant Murine Heart Graft Rejection through Complement-Initiated Necroptosis
R. Ang, N. Chun, A. Ting, P. Heeger.
Immunology Institute, Translational Transplant Research, Icahn School of Medicine at Mount Sinai, New York, NY.
We previously showed that prolonged cold ischemic storage (CIS) of donor B6 hearts results in complement dependent, CTLA4Ig-resistant rejection in BALB/c recipients. In this system,…
2018 American Transplant Congress
How Safe is Crossing the ABO Blood Group Barrier? A Meta-Analysis to Determine the Additive Risk of ABO-Incompatible Kidney Transplantation
A. de Weerd, M. Betjes.
Nephrology and Kidney Transplantation, Erasmus Medical Center, Rotterdam, Netherlands.
Background ABO blood group-incompatible (ABOi) kidney transplantation is considered a safe procedure, with non-inferior outcomes in large cohort studies. Its contribution to living kidney transplantation…
2018 American Transplant Congress
Frailty Assessment Pilot Study in Older Kidney Transplant Recipients
B. Abdalla, B. Hale-Durbin, J. Schaenman, C. Lee, G. Danovitch.
UCLA, Los Angeles, CA.
Older patients are more often being considered for kidney transplantation, however many candidates are on the waitlist for several years. We sought to evaluate the…
2018 American Transplant Congress
Anticoagulation in Pediatric Liver Transplantation; the Pros and Cons
M. Werner,¹ R. de Kleine,¹ M. de Boer,¹ V. de Meijer,¹ R. Scheenstra,² H-.J. Verkade,² F. Bodewes,² S. Bontemps,³ T. Lisman,¹ R. Porte.¹
¹HPB Surgery & Liver Transplantation, University Medical Center Groningen, Groningen, Netherlands; ²Pediatric Gastroenterology & Hepatology, University Medical Center Groningen, Groningen, Netherlands; ³Pediatric Intensive Care, University Medical Center Groningen, Groningen, Netherlands.
Background: Hepatic artery thrombosis (HAT) and portal vein thrombosis (PVT) are serious causes of morbidity and mortality after pediatric orthotopic liver transplantation (OLT). To minimize…
2018 American Transplant Congress
Pancreas Transplant Alone (PTA) Outcome is Best in Brittle Diabetic Patients without Advanced Nephropathy
M. Laftavi,¹ A. Gruessner,² O. Pankewycz,¹ B. Kaylene,² S. Sidharth,² R. Gruessner.
¹SUNY Upstate Medical University, Syracuse, NY; ²SUNY Downstate Medical Center, Brooklyn, NY.
Introduction: Although the overall number of pancreas transplants in combination with or after a kidney transplant have declined, the number of PTA has remained relatively…